{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T05:26:57Z","timestamp":1649136417691},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.leukres.2014.07.007","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T21:03:45Z","timestamp":1406581425000},"page":"1156-1157","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elderly CML patients\u2019 treatment: Considering not only physician's judgment but also co-morbidity indexes"],"prefix":"10.1016","volume":"38","author":[{"given":"Ferm\u00edn","family":"S\u00e1nchez-Guijo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.leukres.2014.07.007_bib0005","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/cncr.26679","article-title":"Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy","volume":"118","author":"Huang","year":"2012","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2014.07.007_bib0010","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.leukres.2011.01.017","article-title":"Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study","volume":"35","author":"Sanchez-Guijo","year":"2011","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.leukres.2014.07.007_bib0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40265-014-0207-7","article-title":"First-line treatment of newly diagnosed elderly patients with chronic myeloid leukemia: current and emerging strategies","volume":"74","author":"Gugliotta","year":"2014","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.leukres.2014.07.007_bib0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/17474086.2013.835697","article-title":"The frontline treatment of chronic myeloid leukemia in the chronic phase: current clinical decisions and future prospects for treatment","volume":"6","author":"Jain","year":"2013","journal-title":"Expert Rev Hematol"},{"issue":"7","key":"10.1016\/j.leukres.2014.07.007_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ajh.23180","article-title":"Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia","volume":"87","author":"Jabbour","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2014.07.007_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/asheducation-2010.1.237","article-title":"Comorbidities and hematopoietic cell transplantation outcomes","volume":"2010","author":"Sorror","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.leukres.2014.07.007_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity: a critical review of available methods","volume":"56","author":"de Groot","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.leukres.2014.07.007_bib0040","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.leukres.2014.06.020","article-title":"Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival","volume":"38","author":"Breccia","year":"2014","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.leukres.2014.07.007_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.23330","article-title":"Long-term safety and efficacy of imatinib mesylate (Gleevec(R)) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study","volume":"88","author":"Rousselot","year":"2013","journal-title":"Am J Hematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261400229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261400229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T05:20:52Z","timestamp":1538371252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521261400229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S014521261400229X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2014.07.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elderly CML patients\u2019 treatment: Considering not only physician's judgment but also co-morbidity indexes","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.06.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}